Skip to main content

International Journal of Clinical Oncology

Ausgabe 10/2021

Inhalt (25 Artikel)

Review Article

Radiotherapy role in non-seminomatous germ cell tumors, radiobiological and technical issues of an unexplored scenario

Giulio Francolini, Luca Eolo Trodella, Giulia Marvaso, Fabio Matrone, Luca Nicosia, Giorgia Timon, Lucia Ognibene, Annamaria Vinciguerra, Ciro Franzese, Paolo Borghetti, Stefano Arcangeli

Open Access Review Article

Hereditary pancreatic cancer

Kodai Abe, Minoru Kitago, Yuko Kitagawa, Akira Hirasawa

Original Article

Second primary cancers: a retrospective analysis of real world data using the enhanced medical research engine ConSoRe in a French comprehensive cancer center

Pierre-Etienne Heudel, Béatrice Fervers, Thierry Durand, Sylvie Chabaud, Anne-Sophie Michallet, Frédéric Gomez, Michel Rivoire, Thomas Bachelot, Line Claude, Catherine Chassagne-Clement, Franck Pilleul, Thomas Mognetti, Bruno Russias, Jean-Luc Soubirou, Gisèle Chvetzoff, David Pérol, Jean-Yves Blay

Original Article

Outcome of patients with newly diagnosed primary CNS lymphoma after high-dose methotrexate followed by consolidation whole-brain radiotherapy and cytarabine: an 8-year cohort study

Pokpong Piriyakhuntorn, Thanawat Rattanathammethee, Sasinee Hantrakool, Chatree Chai-Adisaksopha, Ekarat Rattarittamrong, Adisak Tantiworawit, Lalita Norasetthada

Open Access Original Article

A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma

Makoto Tahara, Susumu Okano, Tomohiro Enokida, Yuri Ueda, Takao Fujisawa, Takeshi Shinozaki, Toshifumi Tomioka, Wataru Okano, Merrill A. Biel, Kosuke Ishida, Ryuichi Hayashi

Original Article

Incurable locoregional disease is a strong poor prognostic factor in recurrent or metastatic squamous cell carcinoma of the head and neck

Ari Nishimura, Tomoya Yokota, Satoshi Hamauchi, Yusuke Onozawa, Hiromichi Shirasu, Takanori Kawabata, Hirofumi Ogawa, Tsuyoshi Onoe, Yoshiyuki Iida, Takashi Mukaigawa, Hirofumi Yasui

Original Article

SERPINE2 is an oral cancer-promoting factor that induces angiogenesis and lymphangiogenesis

Tomonori Sasahira, Miyako Kurihara-Shimomura, Hiroyuki Shimomura, Tadaaki Kirita

Original Article

Osteogenic and brain metastases after non-small cell lung cancer resection

Tetsuya Mizuno, Hayato Konno, Toshiyuki Nagata, Mitsuhiro Isaka, Yasuhisa Ohde

Open Access Original Article

Elevated expression of the RNA‐binding motif protein 43 predicts poor prognosis in esophageal squamous cell carcinoma

Yong Li, Li-Li Liu, Rui Hu, Qi Sun, Xiao-Bo Wen, Rong-Zhen Luo, Shu-Mei Yan

Original Article

Retrospective analysis of neoadjuvant chemotherapy followed by surgery versus definitive chemoradiotherapy with proton beam for locally advanced esophageal squamous cell carcinoma

Koichi Ogawa, Hitoshi Ishikawa, Katsuji Hisakura, Yuichi Hiroshima, Toshikazu Moriwaki, Takeshi Yamada, Yoshiyuki Yamamoto, Yoshimasa Akashi, Yohei Owada, Yusuke Ohara, Tsuyoshi Enomoto, Kinji Furuya, Manami Doi, Osamu Shimomura, Kazuhiro Takahashi, Shinji Hashimoto, Hideyuki Sakurai, Tatsuya Oda

Original Article

Serum zinc deficiency in patients after gastrectomy for gastric cancer

Tsutomu Namikawa, Shigeto Shimizu, Keiichiro Yokota, Nobuhisa Tanioka, Jun Iwabu, Masaya Munekage, Sunao Uemura, Hiromichi Maeda, Hiroyuki Kitagawa, Michiya Kobayashi, Kazuhiro Hanazaki

Original Article

Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701

Tomono Kawase, Hiroshi Imamura, Masahiro Goto, Yutaka Kimura, Shugo Ueda, Jin Matsuyama, Kazuhiro Nishikawa, Naotoshi Sugimoto, Junya Fujita, Takao Tamura, Norimasa Fukushima, Hisato Kawakami, Daisuke Sakai, Yukinori Kurokawa, Toshio Shimokawa, Taroh Satoh

Original Article

Clinicopathological features of sporadic MSI colorectal cancer and Lynch syndrome: a single-center retrospective cohort study

Yujiro Nakayama, Takeru Iijima, Takuhiko Inokuchi, Ekumi Kojika, Misato Takao, Akinari Takao, Koichi Koizumi, Shin-ichiro Horiguchi, Tsunekazu Hishima, Tatsuro Yamaguchi

Original Article

Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma

Norifumi Iseda, Shinji Itoh, Tomoharu Yoshizumi, Takahiro Tomiyama, Akinari Morinaga, Tomonari Shimagaki, Huanlin Wang, Takeshi Kurihara, Takeo Toshima, Yoshihiro Nagao, Noboru Harada, Yoshinao Oda, Masaki Mori

Original Article

Lymphocyte–C-reactive protein ratio as a prognostic marker associated with the tumor immune microenvironment in intrahepatic cholangiocarcinoma

Kyohei Yugawa, Shinji Itoh, Tomoharu Yoshizumi, Akinari Morinaga, Norifumi Iseda, Takeo Toshima, Noboru Harada, Kenichi Kohashi, Yoshinao Oda, Masaki Mori

Open Access Original Article

Surgical margin clearance and extended chemotherapy defines survival for synchronous oligometastatic liver lesions of the ductal adenocarcinoma of the pancreas

S. A. Safi, G. Fluegen, A. Rehders, L. Haeberle, S. Fung, V. Keitel, A. Krieg, W. T. Knoefel, N. Lehwald-Tywuschik

Original Article

The novel index using preoperative C-reactive protein and neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with pancreatic cancer

Tomohiko Taniai, Koichiro Haruki, Kenei Furukawa, Shinji Onda, Jungo Yasuda, Yoshihiro Shirai, Takeshi Gocho, Mitsuru Yanagaki, Ryoga Hamura, Hiroaki Shiba, Toru Ikegami

Original Article

Impact of osteopenia on surgical and oncological outcomes in patients with pancreatic cancer

Kyohei Abe, Kenei Furukawa, Tomoyoshi Okamoto, Michinori Matsumoto, Yasuro Futagawa, Koichiro Haruki, Yoshihiro Shirai, Toru Ikegami

Original Article

Frailty is associated with poor prognosis after resection for pancreatic cancer

Kosuke Mima, Hiromitsu Hayashi, Shigeki Nakagawa, Takashi Matsumoto, Shotaro Kinoshita, Kazuki Matsumura, Fumimasa Kitamura, Norio Uemura, Yosuke Nakao, Rumi Itoyama, Takayoshi Kaida, Katsunori Imai, Yo-ichi Yamashita, Hideo Baba

Original Article

Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era

Sei Naito, Tomoyuki Kato, Kazuyuki Numakura, Shingo Hatakeyama, Tomoyuki Koguchi, Shuya Kandori, Yoshihide Kawasaki, Hisanobu Adachi, Renpei Kato, Shintaro Narita, Hayato Yamamoto, Soichiro Ogawa, Sadafumi Kawamura, Wataru Obara, Akihiro Ito, Hiroyuki Nishiyama, Yoshiyuki Kojima, Chikara Ohyama, Tomonori Habuchi, Norihiko Tsuchiya

Original Article

Assessment of surgical outcomes of off-clamp open partial nephrectomy without renorrhaphy for ≥T1b renal tumours

Masaki Nakamura, Yoshiki Ambe, Taro Teshima, Norihide Shirakawa, Hiroki Inatsu, Ryo Amakawa, Yasushi Inoue, Tadashi Yoshimatsu, Shunsuke Imai, Masashi Kusakabe, Teppei Morikawa, Shuji Kameyama, Yoshiyuki Shiga

Original Article

Impact of positive surgical margin status in predicting early biochemical recurrence after robot-assisted radical prostatectomy

Shuichi Morizane, Tetsuya Yumioka, Karen Makishima, Panagiota Tsounapi, Hideto Iwamoto, Katsuya Hikita, Masashi Honda, Yoshihisa Umekita, Atsushi Takenaka

Original Article

Efficacy of local salvage therapy for recurrent uterine cervical cancer after definitive radiotherapy

Shinya Hiraoka, Aya Nakajima, Noriko Kishi, Keiichi Takehana, Hideki Hanazawa, Yukinori Matsuo, Takashi Mizowaki

Open Access Original Article

A phase I study of combined trabectedin and pegylated liposomal doxorubicin therapy for advanced relapsed ovarian cancer

Shunji Takahashi, Munetaka Takekuma, Kenji Tamura, Kazuhiro Takehara, Hiroyuki Nomura, Makiko Ono, Mayu Yunokawa, Daisuke Aoki

Original Article

High expression of miR-195 is related to favorable prognosis in cytogenetically normal acute myeloid leukemia

Longzhen Cui, Tiansheng Zeng, Liyuan Zhang, Yan Liu, Guangsheng Wu, Lin Fu

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.